Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
16.51
+0.11 (0.67%)
At close: Dec 5, 2025, 4:00 PM EST
16.44
-0.07 (-0.42%)
After-hours: Dec 5, 2025, 7:48 PM EST
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $993.04 million as of December 5, 2025. Its market cap has decreased by -61.39% in one year.
Market Cap
993.04M
Enterprise Value
26.71M
1-Year Change
-61.39%
Ranking
Category
Stock Price
$16.51
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $993.04M, an increase of 61.81%. That is a compound annual growth rate of 11.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 993.04M | -67.83% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |